SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-A/A
For Registration of Certain Classes of Securities
Pursuant to Section 12(b) or (g) of the
Securities Exchange Act of 1934
PARADIGM MEDICAL INDUSTRIES, INC.
---------------------------------
(Exact name of registrant as specified in its charter)
DELAWARE 87-0459536
-------- ----------
(State of incorporation or (I.R.S. Employer
organization) Identification Number)
1772 West 2300 South, Salt Lake City, Utah 84119
- ------------------------------------------ ----------
(Address of principal executive offices) (Zip Code)
Securities to be registered pursuant to Section 12(b) of the Act:
Title of each class Name of each exchange on which
to be so registered each class is to be registered
Not Applicable Not Applicable
Securities to be registered pursuant to Section 12(g) of the Act:
Units, Each Unit Consisting of One Share of
Common Stock and One Class A Warrant
(Title of Class)
Common Stock, $.001 Par Value
(Title of Class)
Class A Warrant to Purchase One Share of Common Stock
(Title of Class)
<PAGE>
Item 1. Description of Registrant's Securities to be Registered.
The securities to be registered are as follows: (A) Units,
each Unit consisting of one share of Common Stock and one Class
A Warrant, (B) Common Stock, $.001 par value, and (C) Class A
Warrants, each Class A Warrant to purchase one share of Common
Stock. Information regarding such securities is incorporated by
reference from "Description of Securities" at pages 45-49 of the
preliminary Prospectus included in Registration Statement No.
333-2496, and the most recent amendment which was filed
electronically on June 13, 1996.
<TABLE>
<CAPTION>
Item 2. Exhibits.
<S> <C>
3.1 Certificate of Incorporation**
3.2 Bylaws**
4.1 Specimen Common Stock certificate*
4.2 Specimen Class A Warrant certificate*
* Incorporated by reference from Registration Statement on
Form SB-2, No. 333-2496, as filed on March 19, 1996.
** Incorporated by reference from Form 8-A, as filed on May
14, 1996.
</TABLE>
SIGNATURE
Pursuant to the requirements of Section 12 of the
Securities Exchange Act of 1934, the Registrant has duly caused
this Registration Statement to be signed on its behalf by the
undersigned, thereto duly authorized.
Dated: June 14, 1996.
PARADIGM MEDICAL INDUSTRIES, INC.
By: Thomas F. Motter
President and Chief
Executive Officer